SJS Investment Consulting’s Terns Pharmaceuticals TERN Stock Holding History

SJS Investment Consulting’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$475	–	2980
2026 Q1	$475	Buy	+9	New	+$370	﹤0.01%	1761

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SJS Investment Consulting's TERN Position: Q2 2026 in Review

SJS Investment Consulting sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 9 shares — an estimated $475 sold.

SJS Investment Consulting first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $475 in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

SJS Investment Consulting reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SJS Investment Consulting sold 9 Terns Pharmaceuticals shares in Q2 2026, an estimated $475.
SJS Investment Consulting first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
SJS Investment Consulting's Terns Pharmaceuticals position peaked at $475 in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.